These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12714204)

  • 1. Trends in myocardial infarction treatment in subjects aged 35-64 in Southwestern France, 1986-93.
    Marques-Vidal P; Ruidavets JB; Cambou JP; Ferrières J
    Int J Cardiol; 2003 Apr; 88(2-3):239-45. PubMed ID: 12714204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project.
    Gregor RD; Bata IR; Brownell B; Wolf HK
    Can J Cardiol; 2000 May; 16(5):596-603. PubMed ID: 10833539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
    Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
    Cambou JP; Simon T; Mulak G; Bataille V; Danchin N
    Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug prescription in the post-percutaneous coronary interventions period: results of the ECART study].
    Philippe F; Sebaoun A; Avierinos C; Julien G
    Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):131-6. PubMed ID: 15291168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi).
    Collart P; Coppieters Y; Levêque A
    Eur J Prev Cardiol; 2012 Aug; 19(4):738-45. PubMed ID: 21708835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial infarction case-fatality gradient in three French regions: the influence of acute coronary care.
    Amouyel P; Arveiler D; Cambou JP; Montaye M; Ruidavets JB; Bingham A; Schaffer P; Richard JL
    Int J Epidemiol; 1994 Aug; 23(4):700-9. PubMed ID: 8002182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns of medical treatment in acute myocardial infarction. Observations from the Perth MONICA Project 1984-1990.
    Thompson PL; Parsons RW; Jamrozik K; Hockey RL; Hobbs MS; Broadhurst RJ
    Med J Aust; 1992 Jul; 157(2):87-92. PubMed ID: 1352848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.
    Sanal S; Aronow WS
    J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
    Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
    JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.